tirzepatide health canada approval Zepbound (Mounjaro/Tirzepatide) for weight management approved in Canada! Health Canada Review Cites 7.1M

Semaglutide Weight Loss for Dallas Patients Semaglutide is a GLP-1 receptor agonist an FDA-approved class of medication that helps reduce appetite, slow digestion, and support sustained weight loss

Ejection fraction in heart failure revisited- where does the evidence start

Reduced appetite and food intake : Ozempic's appetite-suppressing effects may lead to decreased overall fluid consumption, as people often obtain significant hydration from foods and beverages consumed with meals

Controlled portions: GLP-1 users have reduced appetite and smaller stomach capacity

Your Optum Rx partner can help you craft design changes and the utilization management structure necessary to help ensure appropriate use of GLP-1 drugs